F-2-isoprostanes are stable lipid peroxidation products of arachidonic acid
and their quantification provides a novel approach to the assessment of ox
idative stress in vivo. F-2-isoprostanes are present in increased amounts i
n adult hypercholesterolemia, but no data exist concerning children. We inv
estigated urinary isoprostaglandin F-2 alpha type ill production as an inde
x of lipid peroxidation in 15 children presenting with type IIa hypercholes
terolemia (serum total cholesterol, 290 [SD +/- 70] mg/dl; low-density Lipo
protein cholesterol, 210 [SD +/- 90] mg/dl) compared with 15 sex- and age-p
aired control children (serum total cholesterol, 160 [SD +/- 20] mg/dl). Ur
inary levels of isoprostaglandin F-2 alpha type III were measured by gas ch
romatography mass spectrometry. Urinary concentrations did not differ signi
ficantly in hypercholesterolemic children compared with control children (8
4.7 [SD +/- 37] vs. 96 [SD +/- 35] pmol/mmol creatinine, respectively). No
significant correlation was found with total cholesterol, low-density-lipop
rotein and high-density-lipoprotein cholesterol, and apolipoprotein B and A
(1) serum levels. F-2-isoprostane urinary levels in children with type IIa
hypercholesterolemia do not differ from those of age- and sex-matched contr
ol children and are not correlated to blood lipid parameters, suggesting th
at hypercholesterolemia is not associated with increased lipid peroxidation
in childhood.